Abstract |
Despite its ubiquity in cosmetic circles and broad general awareness, a literature search of botulinum neurotoxin in JPRAS and BJPS yielded a mere 4 articles germane to cosmesis. A pair each detailing its application in masseteric hypertrophy(1,2) and the use of cryoanalgesia.(3,4) Given that botulinum neurotoxin A is the most commonly used cosmetic treatment, with American figures being most accurate,(5) a review of the background, development and scientific evidence would be perhaps useful, if not overdue, as Plastic Surgeons increasingly incorporate non-surgical interventions into their practices as part of a comprehensive facial rejuvenation strategy.
|
Authors | M G Berry, Jan J Stanek |
Journal | Journal of plastic, reconstructive & aesthetic surgery : JPRAS
(J Plast Reconstr Aesthet Surg)
Vol. 65
Issue 10
Pg. 1283-91
(Oct 2012)
ISSN: 1878-0539 [Electronic] Netherlands |
PMID | 22552262
(Publication Type: Journal Article, Review)
|
Copyright | Copyright © 2012 British Association of Plastic, Reconstructive and Aesthetic Surgeons. Published by Elsevier Ltd. All rights reserved. |
Chemical References |
- Neurotoxins
- Botulinum Toxins, Type A
|
Topics |
- Botulinum Toxins, Type A
(adverse effects, pharmacology, therapeutic use)
- Cosmetic Techniques
(trends)
- Esthetics
- Female
- Forecasting
- Humans
- Injections, Subcutaneous
- Male
- Neurotoxins
(adverse effects, pharmacology, therapeutic use)
- Rejuvenation
- Risk Assessment
- Skin Aging
(drug effects)
- Treatment Outcome
- United Kingdom
|